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Eukaryotic mRNAs possess a blocked 5* end known for RNA viruses that will be discussed later in this review.
Since the discovery of the cap structure in the 1970s,as the cap structure. Capping occurs on nascent RNA
transcripts and is catalyzed by nuclear enzymes. Most many studies have been performed to elucidate its struc-
ture, synthesis, as well as functional role; various reviewsanimal viruses that replicate in the cytoplasm of infected
cells also possess capping activities and produce were devoted to this topic (Shatkin, 1976; Filipowicz,
1978; Banerjee, 1980; Reddy et al., 1992). In contrast,capped mRNAs. This modification is involved in pre-
mRNA processing and transport from the nucleus, re- this short review focuses on the proteins involved in the
capping reaction, many of which have been isolated andcruitment of mature mRNAs to the ribosomes, and in
the protection of mRNAs from degradation (reviewed in: characterized only in recent years.
Reddy et al., 1992).
In the cap structure, a guanosine residue blocks the RNA TRIPHOSPHATASES
5*-terminal base of the mRNA via a unique 5*-5* triphos-
Since the enzymatic activities required for the synthe-
phate linkage GpppN, where the penultimate ‘‘N’’ nucleo-
sis of the cap structure are found in many purified virions,
side is derived from the RNA transcript. The blocking
viruses have been extensively used to define the pro-
guanosine residue of almost all cellular and viral mRNAs
cesses involved in cap formation. The cytoplasmic DNA
contains a methyl group at the N-7 position (m7GpppN).
vaccinia virus capping enzyme, a heterodimeric protein
In small nuclear RNAs, m2,7GpppN or m2,2,7GpppN cap
composed of 95- and 33-kDa subunits, is encoded by
structures are often found instead of m7GpppN (Vartape-
the viral D1 and D12 genes and has been extensively
tian and Bogdanov, 1987; Furuichi and Shatkin, 1989;
analyzed (Martin et al., 1975). This protein complex is
Liou and Blumenthal, 1990; Reddy et al., 1992). Further-
able to perform all the reactions required for the synthe-
more, in both mRNA and small nuclear RNA, the 5*-termi-
sis of the cap structure since it has RNA triphosphatase,
nal penultimate base and its adjoining residue are some-
guanylytransferase, and methyltransferase activities
times methylated in the ribose moiety or in the N-6 posi-
(Venkatesan et al., 1980). The triphosphatase and guany-
tion of adenosine when it is found at the penultimate
lyltransferase reactions are catalyzed by the amino-termi-
position.
nal 60 kDa of the D1 subunit. Mutations in this subunit
The cap structure is synthesized by three enzymatic
inactivating one activity without affecting the other have
reactions in which the 5*-triphosphate terminus of a pri-
been described and this suggests the existence of two
mary transcript is cleaved to a diphosphate-terminated
distinct functional domains responsible for triphospha-
RNA by an RNA triphosphatase and capped with GMP
tase and guanylyltransferase activities (Cong and Shu-
by an RNA guanylyltransferase. Finally, an RNA (guanine-
man, 1995). Kinetic studies have established that the
7-) methyltransferase catalyzes the transfer of a methyl
conversion of triphosphate to diphosphate ends by the
group from S-adenosylmethionine to the N-7 position of
multifunctional vaccinia capping enzyme is 100-fold
the blocking guanosine. This pathway seems to apply to
faster than GMP transfer to the RNA acceptor molecules
all cellular capping enzymes, although few examples
(Venkatesan et al., 1980). This property of the vaccinia
have been characterized in details; however, some ex-
enzyme probably ensures that the guanylyltransferase
ceptions to this general mechanism have been described
has little or no exposure at all to triphosphate-terminated
RNAs. This is of importance since it has recently been
observed that two vaccinia virus RNA triphosphatase-1 To whom correspondence and reprint requests should be ad-
dressed. defective mutants can transfer GMP to 5*-triphosphate
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RNA ends to produce an unusual tetraphosphate cap degenerate motif seems to be shared by the vaccinia
virus capping enzyme D1 subunit (RPNTSLE), West Nilestructure GppppA . . . (Yu and Shuman, 1996). Synthesis
of small amounts of free dinucleoside tetraphosphate virus NS3 (RTNTILE), and reovirus l1 protein (RDE-
TGLM). These motifs are also found on various putativehas been previously reported during in vitro transcription
with cytoplasmic polyhedrosis virus, a dsRNA virus of the RNA triphosphatases of other flaviviruses and DNA vi-
ruses. Interestingly, a substitution of the glutamate resi-Reoviridae family, and vaccinia virus (Smith and Furuichi,
1982). Studies have also demonstrated that the guanylyl- due in this latter motif of the vaccinia virus capping en-
zyme inactivates the triphosphatase but does not affecttransferases from avian reovirus and yeast Saccharo-
myces cerevisiae can transfer the GMP moiety to a GTP the guanylyltransferase activity (Yu and Shuman, 1996).
This supports the idea that these consensus motifs haveacceptor yielding GppppG (Martinez-Costas et al., 1995;
Wang and Shatkin, 1984). The biological significance, if a functional significance, although further studies will be
needed to firmly establish their exact nature and impor-any, of tetraphosphate capping is not currently known
and there is still no evidence that formation of tetraphos- tance.
Early attempts to demonstrate the 5*-RNA triphospha-phate caps occurs during transcription of viral mRNAs
in vivo. However, dinucleoside tetraphosphates (GppppG tase activity in cellular extracts were unsuccessful mainly
due to the abundant presence of contaminant, nonspe-and AppppA) were found in vivo in several mammalian
cells and in embryos of other eukaryotic organisms, sug- cific, nucleotide phosphohydrolase activities (Yagi et al.,
1983). More recently, numerous improvements in proteingesting that tetraphosphate capping by cellular enzymes
occurs to a certain extent (Finamore and Warner, 1963; purification techniques and the use of recombinant tech-
nology have allowed the identification of RNA triphospha-Oikawa and Smith, 1966; Rapaport and Zamecnik, 1976).
All these observations stress the importance of RNA tri- tases from a variety of sources. Purified cellular RNA
triphosphatases were isolated from rat liver cells, thephosphatase for the synthesis of usual triphosphorylated
cap structure. brine shrimp Artemia salina, and the yeast S. cerevisiae
(Yagi et al., 1983, 1984; Itoh et al., 1984). These RNAThe RNA triphosphatase component of the vaccinia
virus capping enzyme hydrolyzes the g-phosphate of tri- triphosphatases are all specific to the removal of 5*-
g-phosphate from RNA chains without attacking the b-phosphate-terminated RNA and can also cleave the g-
phosphate out of free nucleoside triphosphates. Compet- phosphoryl group. Further studies revealed that the na-
tive yeast capping enzyme has both RNA triphosphataseitive inhibition and simultaneous mutational inactivation
of RNA triphosphatase and nucleoside triphosphatase and guanylyltransferase activities (Itoh et al., 1987). How-
ever, these activities reside on separate polypeptides,functions suggest that both reactions occur at a single
active site (Yu and Shuman, 1996; Myette and Niles, encoded by different genes (Shibagaki et al., 1992). In
contrast, all attempts to separate the two activities of the1996b). However, the observation that the Km for ATP
is 3 orders of magnitude higher than for triphosphate- shrimp or rat enzymes were unsuccessful and it appears
that both activities are exerted by a single polypeptideterminated poly(A) suggests that RNA is the preferred,
and most likely physiological, substrate (Myette and chain, although proteolytic digestion can separate the
functional domains of the brine shrimp protein (Yagi etNiles, 1996a).
An RNA triphosphatase activity has been assigned to al., 1984).
the NS3 protein of the West Nile virus (flavivirus, single-
stranded RNA) (Wengler and Wengler, 1993). As for the RNA GUANYLYLTRANSFERASES
vaccinia virus enzyme, the NS3 protein is also a multi-
functional protein; it possesses a protease activity in its Viral-encoded guanylyltransferases have been exten-
sively studied. The formation of a covalent enzyme-gua-amino-terminal part, a helicase activity in the central re-
gion, and the RNA triphosphatase tentatively assigned nylate intermediate has been identified in guanylyltrans-
ferases isolated from a variety of viruses. In the majorityto the carboxy-terminal domain (Wengler et al., 1991; Tai
et al., 1996; Wengler and Wengler, 1993). It has been of cases, the enzyme catalyzes the transfer of a GMP
residue from GTP to the 5*-diphosphoryl-terminatednoted that the LRPR amino acid sequence found in this
West Nile Virus protein is similar to the vaccinia virus mRNAs following removal of the g-phosphate by RNA
triphosphatase. The GMP is covalently linked to the RNAD1 subunit sequence LKPR. Since no actual structure –
function studies have been performed, the importance guanylyltransferase through a phosphoamide bond to the
e-amino group of a lysine residue (Roth and Hurwitz,of this motif remains purely speculative, although a simi-
lar motif (LRIR) is also present in the reovirus l1 protein 1984). A first exception to this general mechanism has
been noted in the formation of the vesicular stomatitisto which nucleoside and RNA triphosphate phosphohy-
drolase activities were recently assigned (Bartlett and virus cap structure. Although the mechanistic details are
not currently understood, the GpppA . . . cap is formedJoklik, 1988; Noble and Nibert, 1997; Bisaillon et al., 1997
and unpublished data). Furthermore, another somewhat from the a- and b-phosphates of a GTP molecule and
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from a monophosphorylated RNA acceptor, in contrast of the S. cerevisiae capping enzyme is lethal in vivo and
specific residues in motif IV (Asp-225 and Gly-226) andto the conventional pathway in which a- and b-phos-
phates are derived from the RNA molecule. Furthermore, V (Lys-249 and Asp-257) are also essential (Shuman et
al., 1994). Similarly, mutational analysis of the vacciniathere is no apparent binding of guanine nucleotides
(GTP, GDP, GMP) to any viral polypeptides, raising the virus guanylyltransferase has established that specific
residues in motifs III, IV, and V are important for GTPpossibility of a completely different mechanism of cap
formation (reviewed in: Shuman, 1997). Another apparent binding and GMP transfer from the enzyme to the RNA
acceptor (Cong and Shuman, 1995). Thus, the conservedexception is the birnavirus bursal disease virus p90 pro-
tein, a putative guanylyltransferase identified through its motifs in addition to the GMP binding lysine per se are
important for enzyme function and this suggests a com-ability to form an enzyme-guanylate intermediate, al-
though no actual transfer of the GMP to the RNA acceptor mon structural basis for covalent nucleotidyl transfer by
these enzymes.molecule has been demonstrated (Spies and Mu¨ller,
1990); in this case, a phosphodiester linkage seems to The mRNAs of alphaviruses (positive-strand RNA vi-
ruses; e.g., Sindbis and Semliki Forest virus) harbor abe present between the GMP and a serine or threonine
residue of the protein. cap structure synthesized by the nsP1 protein that has
both guanylyltransferase and (guanosine-7-) methyltrans-Compared to RNA triphosphatases, determination of
the primary structure of RNA guanylyltransferases from ferase activities. However, it was recently demonstrated
that the guanine nucleotide bound to nsP1 is exclusivelymany viruses, as well as S. cerevisiae, has allowed a
better knowledge of the active site and catalytic mecha- m7GMP, instead of the usual GMP (Ahola and Ka¨a¨ria¨inen,
1995). This property is unique to the alphaviruses nsP1nism. A lysine-containing motif, KxDG, is conserved
among guanylyltransferases encoded by DNA viruses protein as all other known guanylyltransferases (vaccinia
virus, reovirus, HeLa cells, rat liver cells, and S. cerevis-(vaccinia virus, Shope fibroma virus, African swine fever
virus) and the yeasts S. cerevisiae and S. pombe (Cong iae) are only able to form a linkage with GMP (and dGMP)
and not m7GMP. It was therefore proposed that methyla-and Shuman, 1993; Shuman et al., 1994). This motif is
also conserved at the active site of polynucleotide li- tion of GTP by nsP1 precedes covalent adduct formation
and that m7GTP is the true substrate donor for the guany-gases which, like capping enzymes, catalyze an enzy-
matic reaction via the formation of a covalent Lys-nucleo- lyltransferase reaction (Ahola and Ka¨a¨ria¨inen, 1995). This
suggests that the unique nsP1-m7GMP complex couldside monophosphate intermediate (Lindahl and Barnes,
1992). On the basis of mutational analysis and peptide be a target in designing drugs that specifically inhibit the
capping of alphavirus mRNAs. It is worth mentioning thatmapping, Lys-260 within the KTDG motif of the vaccinia
guanylyltransferase was defined as the active site resi- the characteristically conserved motifs found in guanylyl-
transferases of DNA viruses are not found in the se-due involved in radioactive GMP covalent binding; similar
approaches also identified Lys-70 within the KTDG motif quence of alphavirus nsP1 protein from various isolates.
A similar situation is also observed with the reovirus l2of the yeast capping enzyme (Cong and Shuman, 1993;
Schwer and Shuman, 1994). Furthermore, since the yeast protein, rotavirus VP3, and bluetongue virus VP4, all viral
guanylyltransferases from viruses of the Reoviridae fam-guanylyltransferase is essential for cell growth, it is pos-
sible to test mutational effects on enzyme function in ily (Seliger et al., 1987; Mitchell and Both, 1990; Yu et al.,
1987). These enzymes form a covalent enzyme-guanylatevivo; conservative (Arg) or nonconservative (Ala) substitu-
tion of Lys-70 abrogates capping enzyme function in vivo intermediate but lack the conserved motifs found in yeast
and DNA virus guanylyltransferases. These enzymes ap-as judged by viability loss (Shuman et al., 1994). Substitu-
tion of the invariant Gly residue with Ala is also lethal, parently evolved differently from other viral and cellular
guanylyltransferases despite their identical enzymaticas expected since this mutation abolished protein-GMP
formation in vitro, as also observed in the vaccinia virus functions. The sequence at the active site of reovirus l2
protein, KPTNG, diverges from the consensus signatureenzyme. In addition to the active guanylyltransferase site
(KxDG), other conserved sequence elements (II, III, IV, of DNA viruses (KxDG) but is related to the murine rotavi-
rus SA-11 VP3 protein sequence (KPTGN) and blue-and V) were also identified in enzymes from DNA viruses
(vaccinia virus, Shope fibroma virus, African swine fever tongue virus VP4 (KLTGD); the Lys(226) residue of the
reovirus l2 protein KPTGN sequence was actually identi-virus), S. cerevisiae, S. pombe, and among members of
the ATP-dependent ligase family (Shuman et al., 1994). fied as the GMP attachment site (Fausnaugh and Shatkin,
1990). Furthermore, another motif seems to be conservedThese elements are all arranged in the same order and
with nearly identical spacing, although their sequence between the reovirus l2 protein (YVRKN), the VP3 protein
of the murine rotavirus SA-11 (YYRYN), and the blue-can be slightly divergent. Individual residues in motifs
III, IV, and V of the yeast capping enzyme were shown tongue virus VP4 (YKRKM). Mutagenesis of these resi-
dues could eventually reveal important amino acids in-to be essential for capping enzyme function in vivo. Sub-
stitution of the highly conserved Glu residue in motif III volved in guanylate binding or GMP transfer from the
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enzyme to the acceptor mRNA molecules in this class defined; where U designates a bulky hydrophobic amino
acid residue, o represents a small residue (G, A, or S),of proteins.
and x is any amino acid (Ingrosso et al., 1989). The impor-
tance of the G-loop in binding of the methyl donor (S-METHYLTRANSFERASES
adenosylmethionine) has been suggested by mutational
analysis of a DNA methyltransferase, an unrelated en-Methyltransferases are the third key enzymes in the
formation of the cap structure. Early biochemical studies zyme that nevertheless uses S-adenosylmethionine as a
methyl donor for DNA methylation (Willcock et al., 1994).have focused primarily on the native heterodimeric vac-
cinia virus capping enzyme which, as stated previously, The G-loop is found in the N-terminal-portion of the
NS5 protein of different flaviviruses and in the C-terminalalso catalyzes the (guanosine-7-) methylation. It has been
shown that the carboxy-terminal region of the D1 subunit portion of the l2 protein of reovirus, although no actual
enzymatic activity has been demonstrated for these dif-has a low intrinsic methyltransferase activity, which can
be stimulated by heterodimerization with the D12 subunit ferent proteins (Koonin, 1993). The NS5 protein of flavivir-
uses is a two-domain protein, with its C-terminal domain(Mao and Shuman, 1994). Furthermore, binding studies
have reveal that the C-terminal region of the D1 protein comprising the RNA-dependent polymerase. The reovi-
rus l2 protein has guanylyltransferase activity, mappedcan bind RNA, S-adenosylmethionine (methyl donor), and
GTP (methyl acceptor). Homologous amino acids regions to the N-terminal region of the protein. Isolated l2 failed
to methylate the cap of reovirus mRNA and it has beenare found in the putative methyltransferases of two other
DNA viruses, Shope fibroma virus, and African swine suggested that an interaction with other proteins in the
virus core may be required for the protein to exert itsfever virus. Mutational analysis revealed that a con-
served His-Tyr motif of the vaccinia virus capping enzyme activity (Mao and Joklik, 1991). Interestingly, the reovirus
l2 protein also harbors 3 additional amino acids motifsis likely a component of the active site since substitution
of these amino acids abolished the methyltransferase (L/IXY, TI/TXXXD/E, EXGXXL/I) shared by the methyltrans-
ferases of DNA viruses and S. cerevisiae but apparentlyactivity (Mao and Shuman, 1994).
The study of additional viruses has provided further absent from the flavivirus proteins (Mao et al., 1996). The
significance of these motifs still needs to be established.insights into the role of the methyltransferases in vivo.
Many viral methyltransferases, as in vaccinia virus, have Cellular RNA (guanine-7-) methyltransferases have
been isolated from rat liver, HeLa cells and recently froman additional polymerase or guanylyltransferase domain.
This feature distinguishes them from most cellular pro- S. cerevisiae (Mizumoto and Lipmann, 1979; Ensinger
and Moss, 1976; Mao et al., 1995). The yeast methyltrans-teins, which typically appear to have only methyltransfer-
ase activity (Reddy et al., 1992). ferase ABD1 gene was identified on the basis of its se-
quence similarity with the vaccinia virus methyltransfer-The nsP1 proteins of Semliki Forest virus and Sindbis
virus, two positive-strand RNA viruses, also catalyze a ase and represents the first cellular gene known to en-
code a cap methyltransferase (Mao et al., 1995). Deletionmethyltransferase reaction along with their RNA guany-
lyltransferase activity (Mi et al., 1989; Laakkonen et al., of the ABD1 gene is lethal and all mutations that affect
the methyltransferase activity in vitro are either lethal or1994). Substitution of various conserved amino acid resi-
dues of the nsP1 proteins of these two related viruses severely affect cell growth, indicating that cap methyla-
tion is an essential function in vivo (Mao et al., 1996).abolish or greatly reduce the methyltransferase activity
(Wang et al., 1996; Ahola et al., 1997). Not surprisingly, The nucleotides adjacent to the cap structure can also
be methylated to different extents and the resulting struc-all the methyltransferase-negative mutants also loose the
guanylyltransferase activity, confirming that methylation tures are referred to as ‘‘cap 0,’’ ‘‘cap 1,’’ or ‘‘cap 2,’’ corre-
sponding to the number of methylated sugar residuesof GTP is an essential prerequisite for the synthesis of
the covalent guanylate complex in this particular virus (Furuichi and Shatkin, 1989). The role of the ribose meth-
ylations present in the second and third nucleotide fromfamily (Ahola and Ka¨a¨ria¨inen, 1995). These mutations
also lead to a loss of viral infectivity, again supporting the 5*-end of many mRNAs remains unknown, although
some data indicated that these methylations may havethe essential role of mRNA capping. Further evidence
also came from studies of a mutant Sindbis virus in which a stimulatory effect on ribosome binding of ribopolymers
with weak affinities (Muthukrishnan et al., 1976). In higherchanges in the nsP1 protein result in an ability to multiply
under reduced methionine concentration. This novel eukaryotes, the mRNAs contain mainly cap 2 structures,
whereas the mRNAs in lower eukaryotes contain mainlyproperty results from an enhanced affinity of the mutant
methyltransferase for S-adenosylmethionine, the methyl- cap 0. An unusual cap 4 structure is also found in Trypa-
nosoma brucei where the first four residues are 2*-O-donor derivative of methionine (Scheidel et al., 1989).
The amino acid sequence of different viral and cellular methylated (Freistadt et al., 1988). Moreover, when the
5*-penultimate base of viral or cellular mRNAs is adeno-methyltransferases are widely variable but a conserved
sequence element, the G-loop UU[D/E]UooGxo, can be sine, it exists predominantly in a dimethylated form, N6-
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